Brief: Strides Pharma Science Says Unit Gets USFDA EIR Report For Formulations Facility At Chestnut Ridge
Feb 5 (Reuters) - Strides Pharma Science Ltd SRID.NS: UNIT GETS USFDA EIR REPORT FOR FORMULATIONS FACILITY AT CHESTNUT RIDGE Further company coverage: SRID.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Strides Pharma Science
See all newsIndia's Strides Pharma jumps on successful closure of USFDA inspection at Bengaluru facility
Brief: Strides Pharma Science Receives USFDA EIR For Flagship Facility In Bengaluru
Brief: Strides Pharma Science Receives US FDA Establishment Inspection Report For Bengaluru Facility
Brief: Strides Pharma Science June-Quarter Consol Net Profit 1.57 Billion Rupees
Brief: Strides Pharma Science March-Quarter Consol Net Profit 1.27 Billion Rupees